Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension

Medicine and Dentistry

• Gene Expression 100%
• Endothelial Nitric Oxide Synthase 100%
• Monocrotaline-Induced Pulmonary Hypertension 100%
• Bone Marrow Cell 100%
• Tumor Necrosis Factor 75%
• Gelatinase A 75%
• Endothelin 1 75%
• Monocrotaline 75%
• Interleukin 6 75%
• Tissue Inhibitor of Metalloproteinase 2 75%
• Receptor 50%
• Survival Rate 25%
• Intravenous Drug Administration 25%
• Tail 25%
• Bone Marrow Derived Mesenchymal Stem Cell 25%
• Heart Right Ventricle Failure 25%
• Subcutaneous Injection 25%
• Pulmonary Hypertension 25%
• Endothelin A Receptor 25%
• Mesenchymal Stem Cell Transplantation 25%
• Illness 25%

Nursing and Health Professions

• Monocrotaline-Induced Pulmonary Hypertension 100%
• Endothelial Nitric Oxide Synthase 100%
• Tumor Necrosis Factor 75%
• Monocrotaline 75%
• Tissue Inhibitor of Metalloproteinase 2 75%
• Endothelin 1 75%
• Interleukin 6 75%
• Matrix Metalloproteinase 75%
• Receptor 50%
• Moroxydine 25%
• Survival Rate 25%
• Lung Vascular Resistance 25%
• Endothelin A Receptor 25%
• Intravenous Drug Administration 25%
• Mesenchymal Stem Cell Transplantation 25%
• Heart Right Ventricle Failure 25%
• Subcutaneous Injection 25%
• Pulmonary Hypertension 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Endothelial Nitric Oxide Synthase 100%
• Monocrotaline-Induced Pulmonary Hypertension 100%
• Tumor Necrosis Factor 75%
• Monocrotaline 75%
• Tissue Inhibitor of Metalloproteinase 2 75%
• Endothelin 1 75%
• Matrix Metalloproteinase 75%
• Interleukin 6 75%
• Receptor 50%
• Rat Model 25%
• Survival Rate 25%
• Moroxydine 25%
• Heart Right Ventricle Failure 25%
• Endothelin A Receptor 25%
• Subcutaneous Injection 25%
• Pulmonary Hypertension 25%